These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21299400)

  • 1. Role of chronic and acute hyperglycemia in the development of diabetes complications.
    Marcovecchio ML; Lucantoni M; Chiarelli F
    Diabetes Technol Ther; 2011 Mar; 13(3):389-94. PubMed ID: 21299400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes.
    Colette C; Monnier L
    Horm Metab Res; 2007 Sep; 39(9):683-6. PubMed ID: 17846977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postprandial and basal glucose in type 2 diabetes: assessment and respective impacts.
    Monnier L; Colette C; Owens D
    Diabetes Technol Ther; 2011 Jun; 13 Suppl 1():S25-32. PubMed ID: 21668334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical decision making: managing postprandial hyperglycemia.
    Hurel SJ; Mohan V
    J Assoc Physicians India; 2006 Nov; 54():871-6. PubMed ID: 17249256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of post-prandial hyperglycemia--an essential part of good diabetes treatment and prevention of cardiovascular complications.
    Hanefeld M; Temelkova-Kurktschiev T
    Nutr Metab Cardiovasc Dis; 2002 Apr; 12(2):98-107. PubMed ID: 12189909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose metabolism and hyperglycemia.
    Giugliano D; Ceriello A; Esposito K
    Am J Clin Nutr; 2008 Jan; 87(1):217S-222S. PubMed ID: 18175761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the role of incretin mimetic therapy in the management of type 2 diabetes.
    Unger J; Nadeau DA
    J Fam Pract; 2007 Dec; 56(12 Suppl New):S4-S10. PubMed ID: 18664341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rationale for paired pre- and postprandial self-monitoring of blood glucose: the role of glycemic variability in micro- and macrovascular risk.
    Gerich JE; Odawara M; Terauchi Y
    Curr Med Res Opin; 2007 Aug; 23(8):1791-8. PubMed ID: 17610805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postprandial glucose regulation and diabetic complications.
    Ceriello A; Hanefeld M; Leiter L; Monnier L; Moses A; Owens D; Tajima N; Tuomilehto J
    Arch Intern Med; 2004 Oct; 164(19):2090-5. PubMed ID: 15505121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycemic variability: should we and can we prevent it?
    Monnier L; Colette C
    Diabetes Care; 2008 Feb; 31 Suppl 2():S150-4. PubMed ID: 18227477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the postprandial state on nontraditional risk factors.
    Lebovitz HE
    Am J Cardiol; 2001 Sep; 88(6A):20H-5H. PubMed ID: 11576522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycemic control and complications in type 2 diabetes mellitus.
    Stolar M
    Am J Med; 2010 Mar; 123(3 Suppl):S3-11. PubMed ID: 20206730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should minimal blood glucose variability become the gold standard of glycemic control?
    Hirsch IB; Brownlee M
    J Diabetes Complications; 2005; 19(3):178-81. PubMed ID: 15866065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of self-monitoring of blood glucose during the treatment of type 2 diabetes with medications targeting postprandial hyperglycemia.
    Choe C; Edelman SV
    South Med J; 2007 Nov; 100(11):1123-31. PubMed ID: 17984745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of postprandial glucose control.
    Bell DS
    South Med J; 2001 Aug; 94(8):804-9. PubMed ID: 11549192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study.
    Cavalot F; Petrelli A; Traversa M; Bonomo K; Fiora E; Conti M; Anfossi G; Costa G; Trovati M
    J Clin Endocrinol Metab; 2006 Mar; 91(3):813-9. PubMed ID: 16352690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Importance of daily glycemic variability in achieving glycemic targets in type 2 diabetes: role of DPP-4 inhibitors].
    Ampudia-Blasco FJ; Ceriello A
    Med Clin (Barc); 2010 Sep; 135 Suppl 2():33-9. PubMed ID: 21420536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycemic variability and its responses to intensive insulin treatment in newly diagnosed type 2 diabetes.
    Zhou J; Jia W; Bao Y; Ma X; Lu W; Li H; Hu C; Xiang K
    Med Sci Monit; 2008 Nov; 14(11):CR552-8. PubMed ID: 18971871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Postprandial hyperglycemia. Postprandial blood glucose fluctuations, cardiovascular disease and late diabetic complications].
    Madsbad S; Brock B; Schmitz O
    Ugeskr Laeger; 2003 Aug; 165(33):3149-53. PubMed ID: 12968409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of postprandial glucose control on diabetes-related complications: How is the evidence evolving?
    Madsbad S
    J Diabetes Complications; 2016 Mar; 30(2):374-85. PubMed ID: 26541075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.